[Clinical evaluation of 99mTc-N-pyridoxyl-5-methyltryptophan hepatobiliary scintigraphy in hepatocellular carcinoma].
Kashiwagi
T
T
Azuma
M
M
Matsuda
H
H
Yoshioka
H
H
Ishizu
H
H
Mitsutani
N
N
Koizumi
T
T
Kobayashi
Y
Y
D000328:Adult; D000368:Aged; D001659:Biliary Tract / Q000000981:diagnostic imaging*; D006528:Carcinoma, Hepatocellular / Q000000981:diagnostic imaging*; D005260:Female; D006801:Humans; D008099:Liver / Q000000981:diagnostic imaging*; D008113:Liver Neoplasms / Q000000981:diagnostic imaging*; D008297:Male; D008875:Middle Aged; D015609:Organotechnetium Compounds; D011730:Pyridoxal / Q000031:analogs & derivatives*; D011877:Radionuclide Imaging; D013667:Technetium; D014364:Tryptophan / Q000031:analogs & derivatives*; D000509:alpha-Fetoproteins / Q000032:analysis
D015609:Organotechnetium Compounds; D000509:alpha-Fetoproteins; C038081:technetium Tc 99m pyridoxyl-5-methyltryptophan; D011730:Pyridoxal; D013667:Technetium; D014364:Tryptophan